Evidence map›Paper›PMID 37932813›Full record

ArticleParasites & vectors2023

The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era.

Lalita Roy, Kristien Cloots, Surendra Uranw, Keshav Rai, Narayan R Bhattarai, Tom Smekens, Rik Hendrickx, Guy Caljon, Epco Hasker, Murari L Das and 1 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lalita RoyTropical and Infectious Disease Centre, BP Koirala Institute of Health Sciences, Dharan, Nepal. roy_lalita@yahoo.com.
Kristien ClootsDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Surendra UranwDepartment of Internal Medicine, BP Koirala Institute of Health Sciences, Dharan, Nepal.
Keshav RaiDepartment of Microbiology, BP Koirala Institute of Health Sciences, Dharan, Nepal.
Narayan R BhattaraiDepartment of Microbiology, BP Koirala Institute of Health Sciences, Dharan, Nepal.
Tom SmekensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Rik HendrickxDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Antwerp, Belgium.
Guy CaljonDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Antwerp, Belgium.
Epco HaskerDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Murari L DasDepartment of Microbiology, BP Koirala Institute of Health Sciences, Dharan, Nepal.
Wim Van BortelDepartment of Biomedical Sciences and Outbreak Research Team, Institute of Tropical Medicine, Antwerp, Belgium.
B.P. Koirala Institute of Health Sciences · NPInstituut voor Tropische Geneeskunde · BEUniversity of Antwerp · BE

Funding

Instituut voor Tropische Geneeskunde 716228/40/70
6 · The paper itself

Abstract

backgroundVisceral leishmaniasis (VL), a life-threatening neglected tropical disease, is targeted for elimination from Nepal by the year 2026. The national VL elimination program is still confronted with many challenges including the increasingly widespread distribution of the disease over the country, local resurgence and the questionable efficacy of the key vector control activities. In this study, we assessed the status and risk of Leishmania donovani transmission based on entomological indicators including seasonality, natural Leishmania infection rate and feeding behavior of vector sand flies, Phlebotomus argentipes, in three districts that had received disease control interventions in the past several years in the context of the disease elimination effort.

methodsWe selected two epidemiologically contrasting settings in each survey district, one village with and one without reported VL cases in recent years. Adult sand flies were collected using CDC light traps and mouth aspirators in each village for 12 consecutive months from July 2017 to June 2018. Leishmania infection was assessed in gravid sand flies targeting the small-subunit ribosomal RNA gene of the parasite (SSU-rRNA) and further sequenced for species identification. A segment (~ 350 bp) of the vertebrate cytochrome b (cytb) gene was amplified from blood-fed P. argentipes from dwellings shared by both humans and cattle and sequenced to identify the preferred host.

resultsVector abundance varied among districts and village types and peaks were observed in June, July and September to November. The estimated Leishmania infection rate in vector sand flies was 2.2% (1.1%-3.7% at 95% credible interval) and 0.6% (0.2%-1.3% at 95% credible interval) in VL and non-VL villages respectively. The common source of blood meal was humans in both VL (52.7%) and non-VL (74.2%) villages followed by cattle.

conclusionsOur findings highlight the risk of ongoing L. donovani transmission not only in villages with VL cases but also in villages not reporting the presence of the disease over the past several years within the districts having disease elimination efforts, emphasize the remaining threats of VL re-emergence and inform the national program for critical evaluation of disease elimination strategies in Nepal.

Indexed as

Leishmania donovaniLeishmaniasis, VisceralPhlebotomusPsychodidaeAdultAnimalsCattleHumansNepalHost preferenceInfection rateLeishmania donovani transmissionNepalPhlebotomus argentipesSeasonalityVectorVisceral leishmaniasis

Identifiers

PMID37932813
PMCPMC10629032
OpenAlexW4388423022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.